Using AI to Create New Parkinson’s Treatments: Q&A with Matthias Alder

Alder, CEO of Gain Therapeutics, discusses how the Magellan platform was used in the creation of GT-02287.

admin

Leave a Reply

Your email address will not be published. Required fields are marked *

Powered by WordPress | WP Newspaper by WP Mag Plus